FDA-Drug2023-11-15Class I
1% Lidocaine HCl Injection, USP, 50mg/5mL(10mg/mL), Glass ABBOJECT Unit of Use Syringe, packaged as 1 vial and injector per carton, Rx only, Distributed by Hospira Inc., Lake Forest, IL 60045, NDC 0409-4904-11
Pfizer Inc.
Hazard
Presence of Particulate Matter: identified as glass.
Sold states
Nationwide in the US and Puerto Rico. The products were not distributed to government accounts or foreign consignees.
Affected count
21,390 vials
Manufactured in
235 East 42nd Street, New York, NY, United States
Products
1% Lidocaine HCl Injection, USP, 50mg/5mL(10mg/mL), Glass ABBOJECT Unit of Use Syringe, packaged as 1 vial and injector per carton, Rx only, Distributed by Hospira Inc., Lake Forest, IL 60045, NDC 0409-4904-11
Official notice
https://www.accessdata.fda.gov/scripts/ires/index.cfm?Product=D-0101-2024Don't want to check this manually?
We email you a Sunday digest of new federal recalls relevant to parents — free, no credit card. Or upgrade to as-it-happens alerts for the brands you actually own.
Get the Sunday Brief